Special issue: CAR‐T cell therapy for hematological malignancies by Yongxian Hu, He Huang

Get full text

CAR-T Cell Therapy: Advances in Kidney-Related Diseases by Longyuan Wu, Youqin Feng, Yue Huang, Jingjing Feng, Yongxian Hu, He Huang

Get full text

Infections in hematologic malignancy patients treated by CD19 chimeric antigen receptor T‐cell therapy by Linghui Zhou, Elaine Tan Su Yin, Houli Zhao, Shuyi Ding, Yongxian Hu, He Huang

Get full text

γδ T Cell and Other Immune Cells Crosstalk in Cellular Immunity by Ying He, Kangni Wu, Yongxian Hu, Lixia Sheng, Ruxiu Tie, Binsheng Wang, He Huang

Get full text

Cytomegalovirus Retinitis and Retinal Detachment following Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory Multiple Myeloma by Cheng Zu, Yufeng Xu, Yiyun Wang, Mingming Zhang, Houli Zhao, Xiaoyun Fang, He Huang, Yongxian Hu

Get full text

COVID-19 in Hematologic Malignancies: Big Challenges by Yongxian Hu, Linqin Wang, Qu Cui, Elaine Tan Su Yin, Hengwei Wu, Arnon Nagler, He Huang

Get full text

HLA‐matched allogeneic anti‐CD19 CAR‐T therapy in treating a relapsed/refractory acute lymphoblastic leukemia patient with high tumor burden by Yue Huang, Qin Yu, Elaine Tan Su Yin, Guoqing Wei, Wenjun Wu, Alex H. Chang, He Huang, Yongxian Hu

Get full text

PICALM-MLLT10 fusion gene in hematological neoplasms: clinical features, current practices, and prognoses by Ji-nuo Wang, Bangcheng Ye, Fei Cheng, Li Yang, Yongxian Hu, Gaofeng Zheng, Zhen Cai, Jian Yu, Wenjun Wu

Get full text

Outcome of Pneumocystis Jirovecii pneumonia (PcP) in post-CAR-T patients with hematological malignancies by Cheng Zu, Wenxiao Li, Mingming Zhang, Yetian Dong, Shan Fu, Jingjing Feng, Ruimin Hong, He Huang, Yongxian Hu, Junwei Su

Get full text

Cytokine release syndrome was an independent risk factor associated with hypoalbuminemia for patients with relapsed/refractory hematological malignancies after CAR-T cell therapy by Shuyi Ding, Rongrong Chen, Linqin Wang, Cheng Zu, Xiaoyu Zhou, Jianli Zhang, Mingming Zhang, Aiyun Jin, Tingting Wang, Yongxian Hu

Get full text

Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies by Haiqiong Zheng, Houli Zhao, Shi Han, Delin Kong, Qiqi Zhang, Mingming Zhang, Yijin Chen, Meng Zhang, Yongxian Hu, He Huang

Get full text

690 High safety and efficacy of CRISPR-Based non-viral PD1 locus specific Integrated Anti-CD19 CAR-T cells (BRL-201) in treating relapsed or refractory non-Hodgkin’s lymphoma: firs... by Wei Li, Guoqing Wei, He Huang, Mingyao Liu, Mingming Zhang, Yongxian Hu, Wenjun Wu, Biao Zheng, Jiqin Zhang, Jiazhen Cui, Bing Du

Safety and efficacy of autologous and allogeneic humanized CD19-targeted CAR-T cell therapy for patients with relapsed/refractory B-ALL by Tingting Yang, Guoqing Wei, He Huang, Mingming Zhang, Fengmei Song, Yongxian Hu, Yanlei Zhang, Wenjun Wu, Simao Huang, Huijun Xu, Alex H Chang

Get full text

Incidence, clinical characteristics and prognosis of tumor lysis syndrome following B-cell maturation antigen-targeted chimeric antigen receptor-T cell therapy in relapsed/refracto... by Qiqi Zhang, Qiqi Zhang, Qiqi Zhang, Qiqi Zhang, Cheng Zu, Cheng Zu, Cheng Zu, Cheng Zu, Ruirui Jing, Ruirui Jing, Ruirui Jing, Ruirui Jing, Youqin Feng, Youqin Feng, Youqin Feng, Youqin Feng, Yanlei Zhang, Mingming Zhang, Mingming Zhang, Mingming Zhang, Mingming Zhang, Yuqi Lv, Yuqi Lv, Yuqi Lv, Yuqi Lv, Jiazhen Cui, Jiazhen Cui, Jiazhen Cui, Jiazhen Cui, Linhui Zhou, Linhui Zhou, Linhui Zhou, Linhui Zhou, Ye Meng, Ye Meng, Ye Meng, Ye Meng, Linqin Wang, Linqin Wang, Linqin Wang, Linqin Wang, Zenan Cen, Zenan Cen, Zenan Cen, Zenan Cen, Alex H. Chang, Alex H. Chang, Yongxian Hu, Yongxian Hu, Yongxian Hu, Yongxian Hu, He Huang, He Huang, He Huang, He Huang

Get full text

HLA Fully-Mismatched Sibling-Derived CD7 CAR-T Therapy Bridging to Haploidentical Hematopoietic Stem Cell Transplantation for Hepatosplenic γδ T-cell Lymphoma by Xueer Xu, Cheng Zu, Mingming Zhang, Pingnan Xiao, Ruimin Hong, Jingjing Feng, Huijun Xu, Jiazhen Cui, Jian Yu, Jimin Shi, Guoqing Wei, Alex H. Chang, He Huang, Yongxian Hu

Get full text

Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies by Linqin Wang, Yuqi Lv, Linghui Zhou, Shenghao Wu, Yuanyuan Zhu, Shan Fu, Shuyi Ding, Ruimin Hong, Mingming Zhang, Hanjing Yu, Alex H. Chang, Guoqing Wei, Yongxian Hu, He Huang

Get full text

Safety and efficacy of CRISPR-based non-viral PD1 locus specifically integrated anti-CD19 CAR-T cells in patients with relapsed or refractory Non-Hodgkin's lymphoma: a first-in-hum... by Yongxian Hu, Cheng Zu, Mingming Zhang, Guoqing Wei, Wei Li, Shan Fu, Ruimin Hong, Linghui Zhou, Wenjun Wu, Jiazhen Cui, Dongrui Wang, Bing Du, Mingyao Liu, Jiqin Zhang, He Huang

Get full text

Relapsed/Refractory Peripheral T-Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis With UNC13D and CD27 Germline Mutations by Tingting Yang, Rongrong Chen, Mingming Zhang, Ruirui Jing, Jia Geng, Guoqing Wei, Yi Luo, Pingnan Xiao, Ruimin Hong, Jingjing Feng, Shan Fu, Houli Zhao, Jiazhen Cui, Simao Huang, He Huang, Yongxian Hu

Get full text

Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia by Tingting Yang, Yetian Dong, Mingming Zhang, Jingjing Feng, Shan Fu, Pingnan Xiao, Ruimin Hong, Huijun Xu, Jiazhen Cui, Simao Huang, Guoqing Wei, Delin Kong, Jia Geng, Alex H. Chang, He Huang, Yongxian Hu

Get full text

CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies by Yongxian Hu, Jingjing Li, Fang Ni, Zhongli Yang, Xiaohua Gui, Zhiwei Bao, Houli Zhao, Guoqing Wei, Yiyun Wang, Mingming Zhang, Ruimin Hong, Linqin Wang, Wenjun Wu, Mohamad Mohty, Arnon Nagler, Alex H. Chang, Marcel R. M. van den Brink, Ming D. Li, He Huang

Get full text